Literature DB >> 11568081

Inhibition of tumor necrosis factor-alpha improves postischemic recovery of hypertrophied hearts.

C Stamm1, I Friehs, D B Cowan, A M Moran, H Cao-Danh, L F Duebener, P J del Nido, F X McGowan.   

Abstract

BACKGROUND: Tumor necrosis factor (TNF)-alpha has been implicated in the pathogenesis of heart failure and ischemia-reperfusion injury. Effects of TNF-alpha are initiated by membrane receptors coupled to sphingomyelinase signaling and include altered metabolism and calcium cycling, contractile dysfunction, and cell death. We postulate that pressure-overload hypertrophy results in increased myocardial TNF-alpha expression and that it contributes to decreased contractility in hypertrophied infant hearts subjected to ischemia-reperfusion. METHODS AND
RESULTS: Neonatal rabbits underwent aortic banding to induce LV hypertrophy. Myocardial TNF-alpha protein expression increased progressively with LV hypertrophy. Serum TNF-alpha was detected only after the onset of heart failure. Before onset of ventricular dilatation and heart failure (determined by serial echocardiograms), hearts from aortic banded and age-matched control rabbits were perfused in the Langendorff mode and subjected to 45 minutes of ischemia and 30 minutes of reperfusion. Postischemic recovery was impaired in hypertrophied hearts, but addition of neutralizing anti-rabbit TNF-alpha antibody to cardioplegia and perfusate solutions restored postischemic function. This effect was mimicked by treatment with the ceramidase inhibitor N-oleoyl ethanolamine. TNF-alpha inhibition also was associated with faster postischemic recovery of phosphocreatine, ATP, and pH as assessed by (31)P nuclear magnetic resonance spectroscopy. Intracellular calcium handling, measured by Rhod 2 spectrofluorometry, demonstrated lower diastolic calcium levels and higher systolic calcium transients in anti-TNF-alpha treated hearts.
CONCLUSIONS: TNF-alpha is expressed in myocardium during compensated pressure-overload hypertrophy and contributes to postischemic myocardial dysfunction. Inhibition of TNF-alpha signaling significantly improves postischemic contractile function, myocardial energetics, and intracellular calcium handling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11568081     DOI: 10.1161/hc37t1.094851

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

1.  Cardioprotective effects of irbesartan in polymicrobial sepsis : The role of the p38MAPK/NF-κB signaling pathway.

Authors:  N G Yousif; N R Hadi; F Al-Amran; Q A Zigam
Journal:  Herz       Date:  2017-01-31       Impact factor: 1.443

2.  The double-edge sword of TNF-alpha in ischemia-reperfusion injury.

Authors:  Walter N Durán
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-10-10       Impact factor: 4.733

3.  Time-dependent changes of the susceptibility of cardiac contractile function to hypoxia-reoxygenation after myocardial infarction in rats.

Authors:  Kay-Dietrich Wagner; Gunnar Gmehling; Joachim Gunther; Heinz Theres; Karsten Mydlak; Ingolf Schimke; Holger Scholz
Journal:  Mol Cell Biochem       Date:  2002-12       Impact factor: 3.396

Review 4.  Therapeutic inhibition of tumour necrosis factor alpha in patients with heart failure: cooling an inflamed heart.

Authors:  P A Henriksen; D E Newby
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

5.  Histopathological study of time course changes in inter-renal aortic banding-induced left ventricular hypertrophy of mice.

Authors:  Hiroyuki Higashiyama; Masaki Sugai; Hirotaka Inoue; Kaori Mizuyachi; Hiroshi Kushida; Satoshi Asano; Mine Kinoshita
Journal:  Int J Exp Pathol       Date:  2007-02       Impact factor: 1.925

6.  Vascular endothelial growth factor prevents apoptosis and preserves contractile function in hypertrophied infant heart.

Authors:  Ingeborg Friehs; Rodrigo Barillas; Nikolay V Vasilyev; Nathalie Roy; Francis X McGowan; Pedro J del Nido
Journal:  Circulation       Date:  2006-07-04       Impact factor: 29.690

7.  Impaired insulin-signaling in hypertrophied hearts contributes to ischemic injury.

Authors:  Ingeborg Friehs; Hung Cao-Danh; Meena Nathan; Francis X McGowan; Pedro J del Nido
Journal:  Biochem Biophys Res Commun       Date:  2005-05-27       Impact factor: 3.575

Review 8.  Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends?

Authors:  Melissa L Martin; Burns C Blaxall
Journal:  J Cardiovasc Transl Res       Date:  2012-09-27       Impact factor: 4.132

9.  Genetic ablation of interleukin-18 does not attenuate hypobaric hypoxia-induced right ventricular hypertrophy.

Authors:  Danielle R Bruns; Peter M Buttrick; Lori A Walker
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-01-08       Impact factor: 5.464

10.  Effects of myosin heavy chain manipulation in experimental heart failure.

Authors:  Jeanne James; Kan Hor; Michael-Alice Moga; Lisa Ann Martin; Jeffrey Robbins
Journal:  J Mol Cell Cardiol       Date:  2009-10-22       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.